Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (15)
P 4 (1)

Trial Status

Recruiting6
Completed5
Unknown2
Active Not Recruiting2
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT05366699Not ApplicableRecruitingPrimary

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

NCT04908254Not ApplicableCompleted

A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema

NCT07257679Phase 4RecruitingPrimary

Gentle Touch for Post-Mastectomy Lymphedema

NCT05890677Not ApplicableRecruitingPrimary

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

NCT07217288Not ApplicableNot Yet RecruitingPrimary

Complete Decongestive Therapy Versus Non-pneumatic Compression Therapy in Post Mastectomy Lymphedema

NCT07170631Not ApplicableNot Yet Recruiting

Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)

NCT06900023Enrolling By Invitation

The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer

NCT07019740CompletedPrimary

Evaluatıon of sympathetıc Nervous System fındıngs and theır relatıonshıp wıth Symptoms ın patıents wıth Breast Cancer Related Lymphedema

NCT06302361Not ApplicableActive Not Recruiting

Lymphovenous Anastomosis for Breast Cancer Lymphedema

NCT05601037Not ApplicableRecruitingPrimary

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

NCT06532955Not ApplicableRecruiting

The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema

NCT06415396Not ApplicableCompletedPrimary

Effects of Extracorporeal Shock Wave Therapy (ESWT) and Low Intensity Laser Therapy (LLLT) Added to Complete Decongestive Therapy (CDT) on Extremity Volume, Pain Intensity, Functional Status and Quality of Life in Patients With Postmastectomy Stage 2 Lymphedema

NCT05441943Not ApplicableActive Not Recruiting

Lymphaticovenous Anastomosis as Treatment for Lymphedema

NCT05754346Not ApplicableCompletedPrimary

Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema

NCT05610579Not ApplicableCompletedPrimary

The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related Lymphedema

NCT05297643Not ApplicableUnknownPrimary

Effects of Extracorporeal Shock Wave Therapy Added To Complex DecongestiveTherapy In Patıent With Lymphedeme

NCT04888975Not ApplicableRecruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

NCT04328610Not ApplicableUnknownPrimary

To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast Cancer

Showing all 18 trials

Research Network

Activity Timeline